- Enrollment
- 100
- Started
- Dec 2021
- Completion
- Nov 2023
- Locations
- 21
- Countries
- 6
- Updated
- May 2026
Industry sponsor intelligence
EQRx, Inc.Clinical Pipeline.
Lead-sponsor view of EQRx, Inc.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 1
- Avg enrollment
- 100
Pipeline overview
Programs by phase and activity.
Velocity
EQRx, Inc. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 21
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Goserelin → | 1 | 0 | 1 | 0 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All EQRx, Inc. studies.
This page groups studies where EQRx, Inc. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates